US Stocks
/
Gilead Sciences, Inc. Share Price
Gilead Sciences, Inc. Share Price

Gilead Sciences, Inc. Share Price

NASDAQ: GILD | Large Cap
$147.05
+$0.20 (0.14%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Gilead Sciences, Inc. Stock Performance

Open
$146.04
Prev. Close
$146.85
Circuit Range
N/A
Day Range
$144.70 - $147.47
Year Range
$115.43 - $157.26
Volume
1,96,393
Average Traded
$146.24

Gilead Sciences, Inc. Share Price Today

As of 9 October 2026, Gilead Sciences, Inc.'s share price is $147.05. The stock opened at $146.04, compared to its previous close of $146.85. During today's trading session, Gilead Sciences, Inc.'s share price traded between $144.70 and $147.47, with an average price of $146.08. Over the past 52 weeks, the stock has recorded a high of $157.26 and a low of $115.43. In terms of performance, Gilead Sciences, Inc.'s share price has risen by 12.38% over the last six months and is up 22.81% on a year-on-year basis.

Gilead Sciences, Inc. Share Price Chart

$144.70$147.47
L
Show Current Price
H

Gilead Sciences, Inc. Stock Fundamentals & Key Indicators

Market Cap
$182.93B
PE Ratio (TTM)
N/A
Dividend Yield
2.23%
EPS (TTM)
$-2.61
Revenue (TTM)
$29.44B
Return On Equity (TTM)
-27.39%
Profit Margin
28.91%
Debt to Equity
2.22
Quarterly Earnings Growth YoY
-444.26%

Gilead Sciences, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$7.77$7.93$6.96$7.80
Net Profit$3.05$2.18$2.02-$10.50
Net Profit Margin39.25%27.49%29.02%-134.62%
Income ChangeN/A-28.52%-7.34%-619.80%

Gilead Sciences, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$27.28$27.12$28.75$29.44
Net Profit$4.59$5.67$0.48$8.51
Net Profit Margin16.83%20.91%1.67%28.91%
Income ChangeN/A23.53%-91.53%1672.92%

About Gilead Sciences, Inc.

Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).

Gilead Sciences, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$149.44
$147.15
-1.37%
Sep 2026
$147.87
$149.19
+0.24%
Aug 2026
$131.20
$148.84
+14.33%
Jul 2026
$127.19
$130.19
+3.13%
Jun 2026
$133.43
$126.24
-6.11%
May 2026
$130.16
$134.46
+2.76%
Apr 2026
$139.01
$130.84
-6.10%
Mar 2026
$147.87
$139.35
-6.46%
Feb 2026
$141.26
$148.97
+4.92%
Jan 2026
$122.41
$141.98
+15.65%
Dec 2025
$125.84
$122.77
-2.46%
Nov 2025
$119.82
$125.86
+5.11%

GILD Share Price FAQs

What is Gilead Sciences, Inc. share price today?

chevron-up
Gilead Sciences, Inc. share price today is $147.05 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Gilead Sciences, Inc. stock?

chevron-up
The 52 week high of Gilead Sciences, Inc. stock is $157.26, while the 52 week low is $115.43 as of 9 Oct '26.

What is GILD's market capitalisation today?

chevron-up
GILD market capitalisation is $182.93B as of October 9, 2026, at 1:30 am IST.

What is GILD's net income for the last quarter?

chevron-up
GILD's net income for the last quarter is -10.50B USD.

What is the 5 year returns of GILD?

chevron-up
The 5 year returns of GILD is 126.65% as on 9 Oct '26.

What is the high & low stock price of GILD today?

chevron-up
GILD stock price hit a high of $147.47 and low of $144.70 as of 9 Oct '26.

Can I buy GILD shares in India?

chevron-up
Yes. You can buy GILD in India by opening an international trading account.